Home › Type 2 Diabetes › South Carolina › North Charleston
Type 2 Diabetes clinical trials in North Charleston, SC
5 studies for Type 2 Diabetes are looking for participants at sites in and around North Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Monroe Biomedical Research - Charleston, North Charleston
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RecruitingPhase 2
- Monroe Biomedical Research Charleston, North Charleston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Coastal Carolina Research Center, North Charleston
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
RecruitingPhase 2
- Monroe Biomedical Research, LLC, North Charleston
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, North Charleston
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- San Diego, CA17 studies
- Atlanta, GA17 studies
- Birmingham, AL16 studies
Other studies in North Charleston
- Obesity11 studies
- Overweight6 studies
- Crohn's Disease4 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- Heart Failure3 studies
- Attention Deficit Hyperactivity Disorder3 studies
- Hyperuricemia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.